ArticleInvestigational new drugs2021

Anti-transcriptional intermediary factor 1-γ antibody-positive dermatomyositis induced by nivolumab for lung adenocarcinoma: A case report.

Megumu Osaki et al.PubMed ↗Publisher ↗

No numbers read from the abstract.